PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23906561-4	2013	We found, for the first time, that valproate reduced the amount of two key bone proteins; collagen I and osteonectin (SPARC, BM-40) while over 1000 other proteins remained unchanged (Fuller et al., 2010).	Valproic Acid	35-44	secreted protein acidic and cysteine rich	Homo sapiens	118-123	
20568814-6	2010	The collagen-binding glycoprotein, osteonectin (SPARC, BM-40) was one of the few other proteins that were significantly reduced by valproate treatment.	Valproic Acid	131-140	secreted protein acidic and cysteine rich	Homo sapiens	48-53	
20568814-6	2010	The collagen-binding glycoprotein, osteonectin (SPARC, BM-40) was one of the few other proteins that were significantly reduced by valproate treatment.	Valproic Acid	131-140	secreted protein acidic and cysteine rich	Homo sapiens	55-60	
26999801-2	2016	In previous studies we have shown that valproate, another antiepileptic drug, reduced the amount of two key bone proteins, pro-collagen I and osteonectin (SPARC, BM-40), in both skin fibroblasts and cultured osteoblast-like cells.	Valproic Acid	39-48	secreted protein acidic and cysteine rich	Homo sapiens	155-160	
26999801-2	2016	In previous studies we have shown that valproate, another antiepileptic drug, reduced the amount of two key bone proteins, pro-collagen I and osteonectin (SPARC, BM-40), in both skin fibroblasts and cultured osteoblast-like cells.	Valproic Acid	39-48	secreted protein acidic and cysteine rich	Homo sapiens	162-167